| 2015 | | Recurrent Glioblastomas Reveal Molecular Subtypes Associated with Mechanistic Implications of Drug-Resistance. | 김세혁, 우현구 |
| 2015 | | Romo1 is associated with ROS production and cellular growth in human gliomas. | 김세혁 |
| 2022 | | SHMT1 siRNA-Loaded hyperosmotic nanochains for blood-brain/tumor barrier post-transmigration therapy | 정연훈 |
| 2007 | | Sodium selenite induces superoxide-mediated mitochondrial damage and subsequent autophagic cell death in malignant glioma cells. | 손성향, 최경숙 |
| 2015 | | Spontaneous disappearance of Holmes' tremor in a patient with a midbrain cavernous hemangioma. | 윤정한, 이진수 |
| 2010 | | Stereological analysis on migration of human neural stem cells in the brain of rats bearing glioma. | 조경기 |
| 2016 | | Suppression of 14-3-3gamma-mediated surface expression of ANO1 inhibits cancer progression of glioblastoma cells | 김철호, 이복순 |
| 2020 | | Survival, Prognostic Factors, and Volumetric Analysis of Extent of Resection for Anaplastic Gliomas | 노태훈 |
| 2017 | | The added value of the CSF cleft on ADC in distinguishing extra-axial from intra-axial tumors | 정우상 |
| 2022 | | The efficacy of EGFR-tyrosine kinase inhibitor in non-small cell lung cancer patients with synchronous brain metastasis: a real-world study | 강석윤, 김세혁, 노오규, 노태훈, 신승수, 안미선, 오영택, 이현우, 최용원, 최진혁 |
| 2010 | | The growth of brain tumors can be suppressed by multiple transplantation of mesenchymal stem cells expressing cytosine deaminase. | 김성수, 김세중, 서해영, 유승완, 이영돈, 장다영, 조경기 |
| 2018 | | The prevalence of brain abnormalities in boys with central precocious puberty may be overestimated | 이해상, 황진순 |
| 2014 | | TIMP-1 modulates chemotaxis of human neural stem cells through CD63 and integrin signalling. | 이명애, 정선용 |
| 2020 | | Treatment Results for Recurrent Glioblastoma and Alteration of Programmed Death-Ligand 1 Expression After Recurrence | 노태훈 |
| 2023 | | Tumor Habitat Analysis Using Longitudinal Physiological MRI to Predict Tumor Recurrence After Stereotactic Radiosurgery for Brain Metastasis | 이다현 |
| 2020 | | Tumor treating fields plus temozolomide for newly diagnosed glioblastoma: a sub-group analysis of Korean patients in the EF-14 phase 3 trial | 김세혁 |
| 2017 | | Underexpression of HOXA11 Is Associated with Treatment Resistance and Poor Prognosis in Glioblastoma | 김세혁, 우현구 |
| 2015 | | Wnt5a, Ryk and Ror2 expression in glioblastoma subgroups. | 이다근 |
